{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:18:16Z","timestamp":1770059896183,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic heart failure (CHF) is common and is frequently managed by primary care physicians (PCPs). Despite the European Society of Cardiology (ESC) Guidelines, standard treatments for CHF are frequently underutilised, particularly in primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate current drug therapy for CHF in adults with HF diagnosed according to ESC guidelines in the context of the EPICA study. Aetiological features and therapy relevant comorbidities were also analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>EPICA was a community-based epidemiological study conducted in mainland Portugal. The study involved 365 primary care physicians, who evaluated 6300 primary care attendees aged over 25 years. CHF was diagnosed by clinical and echocardiography criteria according to ESC guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Total of 551 cases of CHF were identified, with a mean age of 65\u00b19 years. The estimated overall prevalence of CHF in the Portuguese population was 4.4%; 1.3% with and 1.7% without left ventricular systolic dysfunction (LVSD). There are 6,280,792 people aged &amp;gt;25 years in Portugal, which extrapolates to 261,400 cases of heart failure. About 80% of patients had a history of hypertension, 39% had a history of coronary artery disease and 15% had atrial fibrillation. Only 58% of patients were on angiotensin-converting enzyme (ACE) inhibitors and 7% on beta-blockers. The type of ventricular dysfunction, age and presence of renal failure had little effect on prescription rates. Diuretics were prescribed in 78%. Thiazides were used more frequently in those with preserved systolic function and frusemide in those with left ventricular systolic dysfunction. Digoxin was prescribed more often to patients with than without left ventricular systolic dysfunction (34% vs. 17%; p=0.02). Long-acting nitrates were prescribed to 20% and amiodarone to 8% of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The EPICA study, as in other studies in primary care in Europe, particularly the IMPROVEMENT study, suggests that greater efforts are required to improve training of primary care teams in the management of CHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.ejheart.2004.09.003","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T12:23:58Z","timestamp":1100262238000},"page":"801-806","source":"Crossref","is-referenced-by-count":25,"title":["Aetiology, Comorbidity and Drug Therapy of Chronic Heart Failure in the Real World: The EPICA Substudy"],"prefix":"10.1093","volume":"6","author":[{"given":"F\u00e1tima","family":"Ceia","sequence":"first","affiliation":[{"name":"Department of Medical Therapeutics, Medical Sciences School, New University of Lisbon \u00a0","place":["Portugal"]},{"name":"Servi\u00e7o de Medicina, Hospital S. Francisco Xavier , 1400, Lisboa ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e2ndida","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Medicina, Hospital S. Francisco Xavier , 1400, Lisboa ,","place":["Portugal"]},{"name":"Department of Internal Medicine, Medical Sciences School, New University of Lisbon , Lisbon ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Mota","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Sciences School, New University of Lisbon , Lisbon ,","place":["Portugal"]},{"name":"Servi\u00e7o de Cardiologia, Hospital Pulido Valente , 1750, Lisboa ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Morais","sequence":"additional","affiliation":[{"name":"EPICA Working Group \u00a0","place":["Portugal"]},{"name":"Grupo de Investiga\u00e7\u00e3o EPICA , Av. Ant\u00f3nio Augusto de Aguiar 128, 1050, Lisboa ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Matias","sequence":"additional","affiliation":[{"name":"EPICA Working Group \u00a0","place":["Portugal"]},{"name":"Grupo de Investiga\u00e7\u00e3o EPICA , Av. Ant\u00f3nio Augusto de Aguiar 128, 1050, Lisboa ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Costa","sequence":"additional","affiliation":[{"name":"EPICA Working Group \u00a0","place":["Portugal"]},{"name":"Grupo de Investiga\u00e7\u00e3o EPICA , Av. Ant\u00f3nio Augusto de Aguiar 128, 1050, Lisboa ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio G.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Datamedica Ltd. , Lisbon ,","place":["Portugal"]},{"name":"Datamedica , R. Garcia de Orta 70, 2 D, 1200, Lisboa ,","place":["Potugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,12,14]]},"reference":[{"key":"2026020204011983300_ejhf2004-09-003-bib-0001","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/oxfordjournals.eurheartj.a015223","article-title":"The epidemiology of heart failure","volume":"18","author":"Cowie","year":"1997","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0002","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2796.1995.tb01153.x","article-title":"Heart failure: a growing public health problem","volume":"237","author":"Eriksson","year":"1995","journal-title":"J. Intern. Med"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archinte.159.1.29","article-title":"Congestive heart failure in the community. Trends in incidence and survival in a 10-year period","volume":"159","author":"Senni","year":"1999","journal-title":"Arch. Intern. Med"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/euhj.2000.2291","article-title":"Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak=","volume":"22","author":"Stewart","year":"2001","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/euhj.2000.2493","article-title":"The heart failure epidemic: exactly how big is it=","volume":"22","author":"Cleland","year":"2001","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0006","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1388-9842(02)00034-X","article-title":"Prevalence of chronic heart failure in Southwestern Europe: the EPICA study","volume":"4","author":"Ceia","year":"2002","journal-title":"Eur. J. Heart Fail"},{"issue":"Suppl. I","key":"2026020204011983300_ejhf2004-09-003-bib-0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(98)90012-5","article-title":"Epidemiology of heart failure and ventricular dysfunction","volume":"352","author":"Sharpe","year":"1998","journal-title":"Lancet"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0008","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1053\/euhj.1998.1280","article-title":"Incidence and aetiology of heart failure. A population based study","volume":"20","author":"Cowie","year":"1999","journal-title":"Eur. Heart J"},{"issue":"Suppl. I","key":"2026020204011983300_ejhf2004-09-003-bib-0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000047289","article-title":"Progression from hypertension to heart failure. Mechanisms and management","volume":"92","author":"Cleland","year":"1999","journal-title":"Cardiology"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/euhj.2000.2393","article-title":"Towards a more precise definition of heart failure aetiology","volume":"22","author":"Tavazzi","year":"2001","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0011","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0735-1097(95)00381-9","article-title":"Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective","volume":"26","author":"Vasan","year":"1995","journal-title":"J. Am. Coll. Cardiol"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0012","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","article-title":"Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. Prevalence and mortality in a population-based cohort","volume":"33","author":"Vasan","year":"1999","journal-title":"J. Am. Coll. Cardiol"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.321.7255.215","article-title":"Do patients with suspected heart failure and preserved left ventricular systolic function suffer from \u201cdiastolic heart failure\u201d or from misdiagnosis= A prospective descriptive study","volume":"321","author":"Caruana","year":"2000","journal-title":"BMJ"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0014","first-page":"99","article-title":"An evaluation of the economic costs of heart failure to the National Health Service in the United Kingdom","volume":"6","author":"McMurray","year":"1993","journal-title":"Br. Med. Econ"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.88.1.107","article-title":"Survival after the onset of congestive heart failure in Framingham Heart Study Subjects","volume":"88","author":"Ho","year":"1993","journal-title":"Circulation"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0016","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/oxfordjournals.eurheartj.a015223","article-title":"The epidemiology of heart failure","volume":"18","author":"Cowie","year":"1997","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0017","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1161\/01.CIR.92.9.2764","article-title":"Guidelines for the evaluation and management of heart failure","volume":"92","author":"ACC\/AHA Task Force on Practice Guidelines","year":"1995","journal-title":"Circulation"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0018","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/oxfordjournals.eurheartj.a015339","article-title":"The treatment of heart failure","volume":"18","author":"Task Force of the Working Group on Heart Failure of the European Society of Cardiology","year":"1997","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0019","doi-asserted-by":"crossref","first-page":"s19","DOI":"10.1016\/S0140-6736(98)90015-0","article-title":"Successes and failures of current treatment of heart failure","volume":"352","author":"Cleland","year":"1998","journal-title":"Lancet"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0020","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","article-title":"Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy","volume":"342","author":"Waagstein","year":"1993","journal-title":"Lancet"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0021","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","article-title":"A randomized trial of \u03b2-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS)","volume":"90","author":"CIBIS Investigators and Committees","year":"1994","journal-title":"Circulation"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0022","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N. Engl. J. Med"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0023","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/euhj.2001.2783","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure","volume":"22","author":"Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology","year":"2001","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0024","first-page":"2996","article-title":"ACC\/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary","volume":"104","author":"A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)","year":"2001","journal-title":"Circulation"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1388-9842(99)00039-2","article-title":"Perindopril for elderly people with chronic heart failure: the PEP-CHF study","volume":"1","author":"Cleland","year":"1999","journal-title":"Eur. J. Heart Fail"},{"issue":"Suppl. L","key":"2026020204011983300_ejhf2004-09-003-bib-0026","first-page":"L36","article-title":"Towards the better treatment of heart failure","volume":"19","author":"Remme","year":"1998","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0027","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/clc.4960210208","article-title":"Factors determining angiotensin-converting enzyme inhibitor under-utilization in heart failure in a community setting","volume":"21","author":"Philbin","year":"1998","journal-title":"Clin. Cardiol"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0028","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archinte.158.10.1074","article-title":"Temporal patterns in the medical treatment of congestive heart failure angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995","volume":"158","author":"Smith","year":"1998","journal-title":"Arch. Intern. Med"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0029","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/euhj.1998.1343","article-title":"Differences in drug treatment of chronic heart failure between European countries","volume":"20","author":"Van Veldhuisen","year":"1999","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1388-9842(99)00073-2","article-title":"The basics of heart failure management: are they being ignored=","volume":"2","author":"Horan","year":"2000","journal-title":"Eur. J. Heart Fail"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0031","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(00)00601-X","article-title":"Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors","volume":"109","author":"Philbin","year":"2000","journal-title":"Am. J. Med"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0032","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/euhj.2000.2170","article-title":"European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF)","volume":"21","author":"Hobbs","year":"2000","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0033","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0140-6736(02)11601-1","article-title":"Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey","volume":"360","author":"Cleland","year":"2002","journal-title":"Lancet"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0034","first-page":"797","article-title":"The diagnosis of heart failure in primary care: value of symptoms and signs","volume":"6","author":"Fonseca","year":"2004","journal-title":"Eur. J. Heart Fail"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0035","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0021-9681(85)90115-8","article-title":"An analysis of physician's reasons for prescribing long-term digitalis therapy in outpatients","volume":"38","author":"Carlson","year":"1985","journal-title":"J. Chronic. Dis"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0036","first-page":"741","article-title":"Guidelines for the diagnosis of heart failure","volume":"16","author":"Cleland","year":"1995","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0037","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/01621459.1981.10477633","article-title":"The analysis of categorical data from complex sample surveys: chi-squared tests for goodness-of-fit and independence in two-way tables","volume":"76","author":"Rao","year":"1981","journal-title":"J. Am. Stat. Assoc"},{"issue":"5","key":"2026020204011983300_ejhf2004-09-003-bib-0038","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","article-title":"The EuroHeart Failure survey programme- a survey on the quality of care among patients with heart failure in Europe: Part 1. Patient characteristics and diagnosis","volume":"24","author":"Cleland","year":"2003","journal-title":"Eur. Heart J"},{"issue":"5","key":"2026020204011983300_ejhf2004-09-003-bib-0039","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe: Part 2. Treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur. Heart J"},{"issue":"14","key":"2026020204011983300_ejhf2004-09-003-bib-0040","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0041","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archfami.8.5.414","article-title":"Congestive heart failure due to diastolic or systolic dysfunction. Frequency and patient characteristics in an ambulatory setting","volume":"8","author":"Diller","year":"1999","journal-title":"Arch. Fam. Med"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0042","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00115677-199701040-00001","article-title":"Screening for left ventricular dysfunction and chronic heart failure. Should it be done and, if so, how=","volume":"4","author":"Cleland","year":"1997","journal-title":"Dis. Manag. Health Outcomes"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0043","first-page":"77","article-title":"Prevalence, etiology and management of heart failure in general practice","volume":"46","author":"Mair","year":"1996","journal-title":"Br. J. Gen. Pract"},{"issue":"Suppl. L","key":"2026020204011983300_ejhf2004-09-003-bib-0044","first-page":"Ll28","article-title":"Translation of clinical trials into practice","volume":"19","author":"Sharpe","year":"1998","journal-title":"Eur. Heart J"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0045","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jama.1995.03520420052037","article-title":"Temporal patterns of anti-hypertensive medication use among older adults, 1989 through 1992","volume":"273","author":"Psaty","year":"1995","journal-title":"JAMA"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0046","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1388-9842(03)00052-7","article-title":"Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure\u2014Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"5","author":"McMurray","year":"2003","journal-title":"Eur. J. Heart Fail"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0047","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0048","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1388-9842(02)00009-0","article-title":"How patients with heart failure are managed in Portugal","volume":"4","author":"Fonseca","year":"2002","journal-title":"Eur. J. Heart Fail"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0049","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"The Digitalis Investigation Group","year":"1997","journal-title":"N. Engl. J. Med"},{"key":"2026020204011983300_ejhf2004-09-003-bib-0050","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure","volume":"42","author":"Khand","year":"2003","journal-title":"J. Am. Coll. Cardiol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ejheart.2004.09.003","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/6\/6\/801\/66649422\/eurjhf_6_6_801.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/6\/6\/801\/66649422\/eurjhf_6_6_801.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:01:31Z","timestamp":1770022891000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/6\/6\/801\/8446719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,1]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,12,14]]},"published-print":{"date-parts":[[2004,10,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ejheart.2004.09.003","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2004,10]]},"published":{"date-parts":[[2004,10,1]]}}}